Rumors that Yu Jinyi will join Pasteur have been confirmed today.
On the morning of the 16th, Zhang Heping, general manager of Sanofi Pasteur China, announced to employees that from April 19, Yu Jinyi will join Sanofi Pasteur China as the Chief Business Officer (CBO) and become Sanofi Bar A member of the Steward China Management Committee, reports directly to Zhang Heping, and works in Beijing.
Yu Jinyi was formerly Senior Director of Hepatitis Sales at Gilead Sciences China.
Today is also his last working day at Gilead Sciences.
On the 29th of last month, Gilead Sciences announced to employees that Yu Jinyi would leave the company to seek external opportunities.
Afterwards, Geely Deutsche Science adjusted the Chinese business team and established two divisions of hepatitis and HIV.
Previously, Da Mi had introduced that Yu Jinyi graduated from Guangdong Pharmaceutical University with a major in pharmacy, and later obtained an MBA degree from Guangdong University of Foreign Studies.
He is most familiar with his 10-year career at Novartis.
Before joining Gilead Sciences, he was One of Novartis's strategic products is the head of national sales and market access strategy.
On June 15 last year, Yu Jinyi joined Gilead Sciences as the senior director of national sales of the hepatitis team, leading the hepatitis sales team, based in Shanghai.
Original title: Yu Jinyi's whereabouts have been determined, as the chief business officer of Sanofi Pasteur in China